Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US Dollar Strengthens As Loonie Falls; Trump Hikes Tariffs on Canadian Autos After Trade Talks Collapse

US Dollar Strengthens As Loonie Falls; Trump Hikes Tariffs on Canadian Autos After Trade Talks Collapse

MT newswireMT newswire2026/08/24 18:18
02:18 PM EDT, 08/24/2026 (MT Newswires) -- The US dollar strengthened against the Canadian dollar Monday afternoon after trade negotiations between the two countries broke down at the 11th hour. President Trump this morning hiked tariffs on Canadian autos to 50% in an escalation of the trade war. The new tariffs take effect from January 1 next year. Prime Minister Carney over the weekend promised that Canada would retaliate "dollar for dollar". US Treasury Secretary Scott Bessent also unveiled new sanctions against Iran this afternoon. The US dollar was up 0.7% to C$1.3859, on last look. West Texas Intermediate October crude oil futures, the US benchmark, fell 2.6% to $84.79 per barrel. October Brent oil futures, the international benchmark, fell 2.6% to $91.95 a barrel. Meanwhile, Comex gold December futures edged up 0.2% to $4,691.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

After Eli Lilly's nearly 300% surge in four years, Wall Street remains bullish: The "hidden pipeline" beyond GLP-1 is underestimated

Eli Lilly’s share price has surged nearly 300% since the approval of its first GLP-1 drug, with its market capitalization surpassing 1 trillion USD, yet Wall Street remains optimistic about its continued growth. Berenberg has upgraded Eli Lilly’s rating to “Buy," believing that Mounjaro and Zepbound will continue to see strong volume, and that the oral GLP-1 drug could further drive demand. Additionally, Eli Lilly continues to expand into areas such as cancer and sleep disorders, and the potential of its non-obesity-related pipelines remains underestimated by the market.

华尔街见闻2026/09/18 13:21